These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31153760)

  • 1. Impact of marital status on receipt of brachytherapy and survival outcomes in locally advanced cervical cancer.
    Huynh-Le MP; Klapheke A; Cress R; Mell LK; Yashar CM; Einck JP; Mundt AJ; Mayadev JS
    Brachytherapy; 2019; 18(5):612-619. PubMed ID: 31153760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Alimena S; Yang DD; Melamed A; Mahal BA; Worley MJ; Feldman S; Elias KM; Orio PF; Lee LJ; King M
    Gynecol Oncol; 2019 Sep; 154(3):595-601. PubMed ID: 31292103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brachytherapy Improves Survival in Stage III Endometrial Cancer With Cervical Involvement.
    Bingham B; Orton A; Boothe D; Stoddard G; Huang YJ; Gaffney DK; Poppe MM
    Int J Radiat Oncol Biol Phys; 2017 Apr; 97(5):1040-1050. PubMed ID: 28332987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing age predicts poor cervical cancer prognosis with subsequent effect on treatment and overall survival.
    Quinn BA; Deng X; Colton A; Bandyopadhyay D; Carter JS; Fields EC
    Brachytherapy; 2019; 18(1):29-37. PubMed ID: 30361045
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Underutilization of brachytherapy and disparities in survival for patients with cervical cancer in California.
    Mayadev J; Klapheke A; Yashar C; Hsu IC; Kamrava M; Mundt AJ; Mell LK; Einck J; Benedict S; Valicenti R; Cress R
    Gynecol Oncol; 2018 Jul; 150(1):73-78. PubMed ID: 29709291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of quality of care and survival in a three-state cohort of locally advanced cervical cancer patients and development of a predictive model to identify women at risk of incomplete treatment.
    Schad MD; Moore J; Camacho F; Anderson RT; Cantrell LA; Showalter TN
    Medicine (Baltimore); 2019 Aug; 98(33):e16874. PubMed ID: 31415427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Body Radiation Therapy, Intensity-Modulated Radiation Therapy, and Brachytherapy Boost Modalities in Invasive Cervical Cancer: A Study of the National Cancer Data Base.
    OʼDonnell B; Shiao JC; Pezzi TA; Waheed N; Sharma S; Bonnen MD; Ludwig MS
    Int J Gynecol Cancer; 2018 Mar; 28(3):563-574. PubMed ID: 29324547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identifying disparities in brachytherapy delivery for locally advanced cervical cancer.
    Eakin A; Wairiri L; Stadtlander W; Bruegl A; Emerson J; Williamson C; Kahn J
    Brachytherapy; 2023; 22(4):461-467. PubMed ID: 37015846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trends in the utilization of brachytherapy in cervical cancer in the United States.
    Han K; Milosevic M; Fyles A; Pintilie M; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2013 Sep; 87(1):111-9. PubMed ID: 23849695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determinants of Quality Care and Mortality for Patients With Locally Advanced Cervical Cancer in Virginia.
    Showalter TN; Camacho F; Cantrell LA; Anderson RT
    Medicine (Baltimore); 2016 Feb; 95(8):e2913. PubMed ID: 26937934
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Better late than never: Brachytherapy is more important than timing in treatment of locally advanced cervical cancer.
    Korenaga TK; Yoshida EJ; Pierson W; Chang J; Ziogas A; Swanson ML; Chapman JS; Sinha S; Chen LM
    Gynecol Oncol; 2022 Feb; 164(2):348-356. PubMed ID: 34865860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High versus low-dose rate brachytherapy for cervical cancer.
    Patankar SS; Tergas AI; Deutsch I; Burke WM; Hou JY; Ananth CV; Huang Y; Neugut AI; Hershman DL; Wright JD
    Gynecol Oncol; 2015 Mar; 136(3):534-41. PubMed ID: 25575481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Survival Benefit of Adjuvant Brachytherapy After Hysterectomy With Positive Surgical Margins in Cervical Cancer.
    Li R; Shinde A; Chen YJ; Amini A; Lee S; Dellinger T; Han E; Wakabayashi M; Nelson R; Beriwal S; Glaser S
    Int J Radiat Oncol Biol Phys; 2018 Oct; 102(2):373-382. PubMed ID: 29890264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of marriage on stage at diagnosis and survival in women with cervical cancer.
    El Ibrahimi S; Pinheiro PS
    Psychooncology; 2017 May; 26(5):704-710. PubMed ID: 26810012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of marital status on the survival outcomes of cervical cancer: a retrospective cohort study based on SEER database.
    Chen Q; Zhao J; Xue X; Xie X
    BMC Womens Health; 2024 Jan; 24(1):75. PubMed ID: 38281955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Updated Trends in the Utilization of Brachytherapy in Cervical Cancer in the United States: A Surveillance, Epidemiology, and End-Results Study.
    Han K; Colson-Fearon D; Liu ZA; Viswanathan AN
    Int J Radiat Oncol Biol Phys; 2024 May; 119(1):143-153. PubMed ID: 37951548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemoradiation in locally advanced cervical carcinoma: an analysis of cisplatin dosing and other clinical prognostic factors.
    Nugent EK; Case AS; Hoff JT; Zighelboim I; DeWitt LL; Trinkhaus K; Mutch DG; Thaker PH; Massad LS; Rader JS
    Gynecol Oncol; 2010 Mar; 116(3):438-41. PubMed ID: 19896180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marital status is an independent prognostic factor in inflammatory breast cancer patients: an analysis of the surveillance, epidemiology, and end results database.
    Liu YL; Wang DW; Yang ZC; Ma R; Li Z; Suo W; Zhao Z; Li ZW
    Breast Cancer Res Treat; 2019 Nov; 178(2):379-388. PubMed ID: 31414242
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical outcomes following conventional external beam radiotherapy boost in Japanese patients with cervical cancer who are ineligible for intracavitary brachytherapy.
    Ito K; Shimizuguchi T; Karasawa K
    Jpn J Clin Oncol; 2019 Mar; 49(3):270-275. PubMed ID: 30576504
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic factors for locally advanced cervical cancer patients treated by intensity-modulated radiation therapy with concurrent chemotherapy.
    Chen CC; Wang L; Lin JC; Jan JS
    J Formos Med Assoc; 2015 Mar; 114(3):231-7. PubMed ID: 25777974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.